Microvolt T-wave alternans to determine benefit to ICD therapy

Mundy L, Hiller JE
Record ID 32012000230
Authors' recomendations: Based on the good quality evidence it would appear that microvolt T-wave alternans (MTWA) testing is useful for the stratification of high and low risk cardiac patients. An increasing number of patients with a low ejection fraction are currently being implanted with implantable cardioverter defibrillators in Australia and New Zealand. The assessment of MTWA has the potential to determine which patients would be successful candidates for implantation and therefore may potentially reduce costs. HealthPACT has therefore recommended that this technology be referred to the Medical Services Advisory Committee (MSAC) for a full health technology assessment.
Project Status: Completed
Year Published: 2008
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Australia
MeSH Terms
  • Humans
  • Defibrillators, Implantable
  • Heart Diseases
  • Electrophysiologic Techniques, Cardiac
Organisation Name: Adelaide Health Technology Assessment
Contact Address: School of Public Health, Mail Drop 545, University of Adelaide, Adelaide SA 5005, AUSTRALIA, Tel: +61 8 8313 4617
Contact Name: ahta@adelaide.edu.au
Contact Email: ahta@adelaide.edu.au
Copyright: Adelaide Health Technology Assessment (AHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.